NCT02630329

Brief Summary

Objective: To compare vNOTES (vaginal Natural Orifice Transluminal Endoscopic Surgery) and established laparoscopic removal of benign adnexal masses Study design: Randomized controlled/single center/single-blinded/parallel-group/non-inferiority/efficacy trial. Study population: Women aged 18 to 70 years with symptomatic or persistent benign adnexal masses detected by clinical examination and ultrasound. Randomization: Women will be randomly allocated to undergo one of two techniques for removal of the benign adnexal mass immediately before surgery by using a computer generated randomization list. The investigators will use stratified randomization according to the cyst diameter. Intervention: Women will be treated by a surgeon who is not blinded to the treatment allocation and who is equally skilled in performing both techniques. In the intervention group a vNOTES technique will be used. Control: In the control group surgery will be done by a classical laparoscopic technique. Participants, nursing staff and outcome assessors will be blinded. Main study parameters/endpoints: Primary outcomes: successful removal of a benign adnexal mass without spill. Secondary outcomes: the proportion of women discharged the same day based on their own preference; postoperative pain scores using a VAS (Visual Analogue Scale) measured between day 1 till 7 by the participating women following surgery and the total amount of analgesics used as described in the standardized pain treatment protocol between day 1 till 7; postoperative infection defined by lower abdominal pain with fever \> 38°C and positive clinical signs or laboratory findings; per- or postoperative complications according to the Clavien- Dindo classification detected during the first six weeks of surgery; duration of the surgical procedure; incidence and intensity of dyspareunia recorded by the participants at 3 and 6 months by self-reporting using a simple questionnaire and VAS scale; sexual wellbeing recorded by the participants at 3 and 6 months by SSFS (Short Sexual Functioning Scale); direct costs associated up to 6 weeks after the surgical intervention with both procedures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 8, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 15, 2015

Completed
2 months until next milestone

Study Start

First participant enrolled

February 3, 2016

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 16, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 16, 2020

Completed
Last Updated

June 11, 2020

Status Verified

June 1, 2020

Enrollment Period

4.2 years

First QC Date

December 8, 2015

Last Update Submit

June 9, 2020

Conditions

Keywords

NOTESBenign adnexal diseaseLaparoscopy

Outcome Measures

Primary Outcomes (1)

  • Successful removal of adnexal mass without spill

    The proportion of women successfully treated by removing the adnexal mass without spill, using a dichotomous outcome measure, will be used as a measure of efficacy.

    Intraoperative

Secondary Outcomes (11)

  • Discharge from the hospital the day of the surgical intervention

    Dichotomous outcome measured on the day of the surgical intervention

  • Postoperative pain scores

    The first week after the surgical intervention

  • The use of analgesics for postoperative pain

    The first week after the surgical intervention

  • Postoperative infection

    The first six weeks after the surgical intervention

  • Complications

    The first six weeks after the surgical intervention

  • +6 more secondary outcomes

Study Arms (2)

vNOTES adnexectomy

EXPERIMENTAL

Vaginal Natural Orifice Transluminal Endoscopic Surgery

Procedure: vNOTES adnexectomy

LSC adnexectomy

ACTIVE COMPARATOR

Laparoscopic adnexectomy

Procedure: Laparoscopic adnexectomy

Interventions

Surgical removal of one or both adnexa by a natural orifice transluminal endoscopic surgical technique using a colpotomy (transvaginal incision)

vNOTES adnexectomy

Surgical removal of one or both adnexa by transabdominal laparoscopy

LSC adnexectomy

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All women aged 18 to 70 years regardless of parity with a symptomatic adnexal mass presumed to be benign based on ultrasound examination by applying the IOTA simple rules
  • All women aged 18 to 70 years regardless of parity with an asymptomatic persistent adnexal mass presumed to be benign based on ultrasound examination by applying the IOTA simple rules
  • Written informed consent obtained prior to surgery

You may not qualify if:

  • History of hysterectomy by any technique
  • History of rectal surgery
  • Suspected rectovaginal endometriosis
  • Suspected endometriotic cyst
  • Solid adnexal mass
  • High suspicion of adnexal malignancy based on clinical, ultrasound or biochemical findings
  • History of pelvic inflammatory disease, especially prior tubo-ovarian or pouch of Douglas abscess
  • Active lower genital tract infection e.g. Chlamydia, N. gonorrhoeae
  • Virgo
  • Pregnancy
  • Need for other uterine surgical intervention (i.e. endometrial ablation, resection, myomectomy or hysterectomy)
  • Additional pathology necessitating hysterectomy
  • Failure to provide written informed consent prior to surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Imelda Hospital

Bonheiden, Antwerp, 2820, Belgium

Location

Related Publications (6)

  • Wang PH, Lee WL, Juang CM, Tsai WY, Chao HT, Yuan CC. Excision of mature teratoma using culdotomy, with and without laparoscopy: a prospective randomised trial. BJOG. 2001 Jan;108(1):91-4. doi: 10.1111/j.1471-0528.2001.00003.x.

    PMID: 11213011BACKGROUND
  • Baekelandt J. Poor man's NOTES: can it be a good approach for adhesiolysis? A first case report with video demonstration. J Minim Invasive Gynecol. 2015 Mar-Apr;22(3):319. doi: 10.1016/j.jmig.2014.11.001. Epub 2014 Nov 10.

  • Yang YS, Hur MH, Oh KY, Kim SY. Transvaginal natural orifice transluminal endoscopic surgery for adnexal masses. J Obstet Gynaecol Res. 2013 Dec;39(12):1604-9. doi: 10.1111/jog.12108. Epub 2013 Jul 22.

  • Ghezzi F, Cromi A, Uccella S, Bogani G, Serati M, Bolis P. Transumbilical versus transvaginal retrieval of surgical specimens at laparoscopy: a randomized trial. Am J Obstet Gynecol. 2012 Aug;207(2):112.e1-6. doi: 10.1016/j.ajog.2012.05.016. Epub 2012 May 23.

  • Medeiros LR, Rosa DD, Bozzetti MC, Fachel JM, Furness S, Garry R, Rosa MI, Stein AT. Laparoscopy versus laparotomy for benign ovarian tumour. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004751. doi: 10.1002/14651858.CD004751.pub3.

  • Baekelandt JF, De Mulder PA, Le Roy I, Mathieu C, Laenen A, Enzlin P, Weyers S, Mol BWJ, Bosteels JJA. Transvaginal natural orifice transluminal endoscopic surgery (vNOTES) adnexectomy for benign pathology compared with laparoscopic excision (NOTABLE): a protocol for a randomised controlled trial. BMJ Open. 2018 Jan 10;8(1):e018059. doi: 10.1136/bmjopen-2017-018059.

MeSH Terms

Conditions

Adnexal Diseases

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Jan Baekelandt, MD

    Imelda Hospital, Bonheiden

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

December 8, 2015

First Posted

December 15, 2015

Study Start

February 3, 2016

Primary Completion

April 16, 2020

Study Completion

April 16, 2020

Last Updated

June 11, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

Interim analyses of major endpoints will be supplied, in strict confidence, to an independent Data Monitoring and Ethics Committee (DMEC) along with updates on results of other related studies, and any other analyses that the DMEC may request.

Locations